Francis J. Tan, Managing Partner

Frank Tan is a senior C-Suite strategy and corporate development executive who has announced more than $65 billion of M&A transactions over three decades across technology, life sciences, diagnostics, medical devices, industrial, and energy sectors and has served on executive leadership teams at industry leaders in healthcare, technology, and diversified industrials since 2017.

  • Currently leading Corporate Development advisory services for Hayward Brook Partners, LLC focused on internal preparation for and management of acquisitions, divestitures, partnerships, licensing, and strategic planning.

  • Previously, as Senior Vice President of Strategy & Corporate Development, drove strategy development and deal sourcing across W.L. Gore & Associates’ broad materials sciences portfolio representing $5 billion in revenue in medical technology, fabric laminates, cables, filtration, sealants, membranes, venting, protective gear, and fibers comprised of GORE-TEX® and related technologies for industries worldwide.

  • While Senior Vice President of Strategic Development at MKS Instruments, notable transactions included the $6 billion cross-border acquisition of Atotech (sourced and led), an unsolicited $6 billion bid for Coherent in a highly contested, three-way process (architect of hostile approach and the strategic timing of offer withdrawal enabling the successful acquisition of Atotech), and the $320 million cross-border purchase of Photon Control.

  • As Vice President of Corporate Development at global life sciences leader Thermo Fisher Scientific, transformational deals included the $7 billion acquisition of Patheon N.V., $4 billion acquisition of FEI Company, $16 billion acquisition of Life Technologies, $1 billion divestiture of cell culture, gene modulation, and magnetic beads businesses to GE, and $925 million acquisition of One Lambda, increasing TMO’s revenues by 2x and expanding market cap by 4x in seven years. Previous leadership experience also comprised the $7 billion cross-border sale and integration of Millipore into Merck KGaA.

  • Depth and breadth of experience includes Strategy & Corporate Development, Investment Banking / M&A, Private Equity / Venture Capital, Marketing / Operations, Anti-Trust, Carve-Outs, and Post-Merger Integration.

  • Cross-functional leadership continuously demonstrated in organizationally complex environments developing and executing internal and external strategic growth initiatives.

  • Extensive support of acquisition-related anti-trust filing processes in jurisdictions worldwide including preparation and execution of a regulatory-mandated triple carve-out divestiture.

  • Highly focused on talent development and “paying it forward” throughout his career and has enjoyed seeing numerous mentees achieve phenomenal career and personal outcomes.

Frank holds an MBA in Finance and Strategy from the Yale School of Management and a BA in Classics from Amherst College. Favorite activities include cooking, gardening, photography, fine woodworking, and long walks with his Labrador Retriever, Fenway along the eponymous Hayward Brook.